Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.240
-0.050 (-3.88%)
Aug 29, 2025, 4:00 PM - Market closed
Tenon Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Tenon Medical stock have a consensus rating of "Strong Buy" and an average price target of $5.50, which forecasts a 343.55% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $8.00.
Price Target: $5.50 (+343.55%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 9, 2025.
Analyst Ratings
The average analyst rating for Tenon Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +141.94% | Apr 9, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $22 → $8 | Strong Buy | Maintains | $22 → $8 | +545.16% | Nov 15, 2024 |
| Benchmark | Benchmark | Buy Reiterates $24 | Buy | Reiterates | $24 | +1,835.48% | Aug 14, 2024 |
| Benchmark | Benchmark | Buy Maintains $40 → $24 | Buy | Maintains | $40 → $24 | +1,835.48% | Apr 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +38,609.68% | Mar 10, 2023 |
Financial Forecast
Revenue This Year
4.70M
from 3.28M
Increased by 43.52%
Revenue Next Year
8.57M
from 4.70M
Increased by 82.14%
EPS This Year
-1.85
from -11.26
EPS Next Year
-0.92
from -1.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.1M | 9.9M | |||
| Avg | 4.7M | 8.6M | |||
| Low | 4.2M | 7.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 56.6% | 111.3% | |||
| Avg | 43.5% | 82.1% | |||
| Low | 29.6% | 52.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.73 | -0.79 | |||
| Avg | -1.85 | -0.92 | |||
| Low | -1.94 | -1.03 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.